miR‐200c/Bmi1 axis and epithelial–mesenchymal transition contribute to acquired resistance to <scp>BRAF</scp> inhibitor treatmentShujing Liu, Xiaowei Xu, Michael T. Tetzlaff et al.|Pigment Cell & Melanoma Research|2015Cited by 53
[A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].Huazhang Guo, Tao Wang, Wenliang Wang|PubMed|2004Cited by 0